Vaccination with type-1 dendritic cells pulsed with multiple glioma-associated antigen peptides in combination with POLY-ICLC in patients with recurrent malignant glioma

被引：0
|
作者：
Okada, Hideho [1 ]
Lieberman, Frank [1 ]
Kalinski, Pawel [1 ]
Zhu, Xinmei [1 ]
Lunsford, L. Dade [1 ]
Kassam, Amin [1 ]
Mintz, Arlan
Bartlett, David [1 ]
Brown, Charles
Zeh, Herbert [1 ]
Whiteside, Theresa [1 ]
Butterfield, Lisa [1 ]
Hamilton, Ronald [1 ]
Salazar, Andres [2 ]
Pollack, Ian [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Oncovir Inc, Washington, DC USA
来源：
NEURO-ONCOLOGY | 2007年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508 / 508
页数：1
相关论文
共 45 条
  • [1] TYPE 1 DENDRITIC CELL (DC) VACCINES IN COMBINATION WITH POLY-ICLC IN PARTICIPANTS WITH RECURRENT MALIGNANT GLIOMA
    Okada, Hideho
    Lieberman, Frank S.
    Kalinski, Pawel
    Lunsford, L. Dade
    Kassam, Amin
    Mintz, Arlan H.
    Bartlett, David L.
    Brown, Charles K.
    Zeh, Herbert
    Whiteside, Theresa L.
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Salazar, Andres M.
    Pollack, Ian F.
    NEURO-ONCOLOGY, 2009, 11 (02) : 224 - 224
  • [2] Induction of CD8+T Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type-1-Polarized Dendritic Cells and poly-ICLC In Patients with Recurrent Malignant Glioma
    Okada, Hideho
    Kalinski, Pawel
    Kohanbash, Gary
    Reinhart, Todd A.
    Whiteside, Theresa L.
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Potter, Douglas M.
    Pollack, Ian F.
    Salazar, Andres M.
    Lieberman, Frank S.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 917 - 917
  • [3] Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasaEuro
    Pollack, Ian F.
    Jakacki, Regina I.
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Panigrahy, Ashok
    Normolle, Daniel P.
    Connelly, Angela K.
    Dibridge, Sharon
    Mason, Gary
    Whiteside, Theresa L.
    Okada, Hideho
    NEURO-ONCOLOGY, 2016, 18 (08) : 1157 - 1168
  • [4] Induction of Type-1 CTL Responses Against Novel Glioma-associated Antigen (GAA)-Derived Epitopes EPHA2 (883 to 891) and IL-13Ralpha2 (345 to 353) in Patients With Recurrent Malignant Glioma Receiving Type-1 Dendritic Cell (DC) Vaccines in Combination With Poly-ICLC
    Okada, Hideho
    Lieberman, Frank S.
    Ueda, Ryo
    Kalinski, Pawel
    Bartlett, David L.
    Whiteside, Theresa L.
    Butterfield, Lisa H.
    Salazar, Andres M.
    Pollack, Ian F.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 946 - 946
  • [5] IMMUNE RESPONSES AND CLINICAL OUTCOME IN A PILOT STUDY OF VACCINATION WITH GLIOMA-ASSOCIATED ANTIGEN PEPTIDES AND POLY-ICLC IN CHILDREN WITH NEWLY DIAGNOSED MALIGNANT BRAINSTEM AND NON-BRAINSTEM GLIOMAS
    Pollack, Ian
    Jakacki, Regina
    Butterfield, Lisa
    Hamilton, Ronald
    Panigrahy, Ashok
    Potter, Douglas
    Connelly, Angela
    Dibridge, Sharon
    Whiteside, Theresa
    Okada, Hideho
    NEURO-ONCOLOGY, 2014, 16 : 50 - 50
  • [6] INDUCTION OF TYPE-1 CTL RESPONSES AGAINST NOVEL GLIOMA-ASSOCIATED ANTIGEN (GAA)-DERIVED EPITOPES EPHA2 (883-891) AND IL-13 ALPHA 2 (345-353) IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA RECEIVING DENDRITIC CELL (DC) VACCINES IN COMBINATION WITH POLY-ICLC
    Okada, Hideho
    Lieberman, Frank
    Ueda, Ryo
    Fujita, Mitsugu
    Zhu, Xinmei
    Kalinski, Pawel
    Lunsford, L.
    Kassam, Amin
    Mintz, Arlan
    Park, Deric
    Mabold, Jennifer
    Bartlett, David
    Brown, Charles
    Zeh, Herbert
    Whiteside, Theresa
    Butterfield, Lisa
    Hamilton, Ronald
    Salazar, Andres
    Pollack, Ian
    NEURO-ONCOLOGY, 2008, 10 (05) : 808 - 809
  • [7] Vaccine combined with POLY-ICLC treatment promotes the type-1 polarization of the central nervous system glioma environment
    Zhu, Xinmei
    Fujita, Mitsugu
    Ueda, Ryo
    Low, Keri
    Salazar, Andres
    Okada, Hideho
    NEURO-ONCOLOGY, 2007, 9 (04) : 502 - 502
  • [8] COMPARISON OF GLIOMA-ASSOCIATED ANTIGEN PEPTIDE-LOADED VERSUS AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IN MALIGNANT GLIOMA PATIENTS
    Prins, Robert M.
    Everson, Richard
    Soto, Horacio
    Lisiero, Dominique N.
    Young, Emma
    Liau, Linda M.
    NEURO-ONCOLOGY, 2012, 14 : 48 - 49
  • [9] Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients
    Prins, Robert M.
    Wang, Xiaoyan
    Soto, Horacio
    Young, Emma
    Lisiero, Dominique N.
    Fong, Brendan
    Everson, Richard
    Yong, William H.
    Lai, Albert
    Li, Gang
    Cloughesy, Timothy F.
    Liau, Linda M.
    JOURNAL OF IMMUNOTHERAPY, 2013, 36 (02) : 152 - 157
  • [10] Type-1 dendritic cell vaccines in combination with poly-ICLC-association between positive tetramer response and 6-month progression-free survival in patients with recurrent malignant glioma
    Okada, Hideho
    Lieberman, Frank S.
    Hoji, Aki
    Kalinski, Pawel
    Mintz, Arlan H.
    Engh, Johnathan A.
    Park, Deric M.
    Bartlett, David L.
    Zeh, Herbert
    Whiteside, Theresa L.
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Salazar, Andres M.
    Pollack, Ian F.
    CANCER RESEARCH, 2010, 70
12345